Paradice Investment Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Sell |
|
|||||
|
2025
Q1 | $18.4M | Sell |
|
|||||
|
2024
Q4 | $20.6M | Buy |
|
|||||
|
2024
Q3 | $30.3M | Sell |
|
|||||
|
2024
Q2 | $26.8M | Buy |
|
|||||
|
2024
Q1 | $25.4M | Sell |
|
|||||
|
2023
Q4 | $37.1M | Sell |
|
|||||
|
2023
Q3 | $46M | Buy |
|
|||||
|
2023
Q2 | $57.4M | Sell |
|
|||||
|
2023
Q1 | $68.2M | Sell |
|
|||||
|
2022
Q4 | $63.4M | Hold |
|
|||||
|
2022
Q3 | $51M | Buy |
|
|||||
|
2022
Q2 | $63.2M | Sell |
|
|||||
|
2022
Q1 | $82.4M | Sell |
|
|||||
|
2021
Q4 | $110M | Buy |
|
|||||
|
2021
Q3 | $96.3M | Buy |
|
|||||
|
2021
Q2 | $88.8M | Sell |
|
|||||
|
2021
Q1 | $108M | Sell |
|
|||||
|
2020
Q4 | $114M | Sell |
|
|||||
|
2020
Q3 | $83.6M | Sell |
|
|||||
|
2020
Q2 | $77.9M | Buy |
|
|||||
|
2020
Q1 | $69.4M | Buy |
|
|||||
|
2019
Q4 | $75M | Sell |
|
|||||
|
2019
Q3 | $84.2M | Buy |
|
|||||
|
2019
Q2 | $86.9M | Buy |
|
|||||
|
2019
Q1 | $72.2M | Buy |
|
|||||
|
2018
Q4 | $66.9M | Buy |
|
|||||
|
2018
Q3 | $46.6M | Sell |
|
|||||
|
2018
Q2 | $83.8M | Sell |
|
|||||
|
2018
Q1 | $71.4M | Buy |
|
|||||
|
2017
Q4 | $70M | Sell |
|
|||||
|
2017
Q3 | $70.5M | Buy |
|
|||||
|
2017
Q2 | $60.2M | Buy |
|
|||||
|
2017
Q1 | $55.2M | Sell |
|
|||||
|
2016
Q4 | $53.7M | Buy |
|
|||||
|
2016
Q3 | $43.9M | Sell |
|
|||||
|
2016
Q2 | $44.1M | Buy |
|
|||||
|
2016
Q1 | $34.8M | Buy |
|
|||||
|
2015
Q4 | $35.3M | Buy |
|
|||||
|
2015
Q3 | $18.9M | Buy |
|
|||||
|
2015
Q2 | $18.2M | Buy |
|
|||||
|
2015
Q1 | $17.4M | Buy |
|